LUCARELLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 11.317
AS - Asia 4.238
EU - Europa 3.457
SA - Sud America 1.215
Continente sconosciuto - Info sul continente non disponibili 587
AF - Africa 190
OC - Oceania 6
AN - Antartide 1
Totale 21.011
Nazione #
US - Stati Uniti d'America 11.108
SG - Singapore 1.658
IT - Italia 1.213
BR - Brasile 973
CN - Cina 905
HK - Hong Kong 539
SE - Svezia 452
RU - Federazione Russa 432
VN - Vietnam 363
DE - Germania 327
FR - Francia 239
FI - Finlandia 206
GB - Regno Unito 189
BD - Bangladesh 159
IN - India 142
UA - Ucraina 140
CA - Canada 113
AR - Argentina 85
IQ - Iraq 67
BE - Belgio 62
ID - Indonesia 59
CO - Colombia 53
MX - Messico 49
ZA - Sudafrica 48
TR - Turchia 44
SA - Arabia Saudita 41
JP - Giappone 40
CI - Costa d'Avorio 37
NL - Olanda 35
PK - Pakistan 34
VE - Venezuela 31
EC - Ecuador 29
ES - Italia 28
IE - Irlanda 23
PH - Filippine 23
PL - Polonia 23
MA - Marocco 19
TN - Tunisia 18
UZ - Uzbekistan 18
MY - Malesia 15
KE - Kenya 14
EG - Egitto 13
IR - Iran 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
LT - Lituania 12
NP - Nepal 11
AZ - Azerbaigian 10
CL - Cile 10
KR - Corea 9
OM - Oman 9
PY - Paraguay 9
CH - Svizzera 8
HN - Honduras 8
JM - Giamaica 8
PE - Perù 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
BO - Bolivia 7
KZ - Kazakistan 7
AL - Albania 6
CR - Costa Rica 6
DZ - Algeria 6
LB - Libano 6
PS - Palestinian Territory 6
AU - Australia 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IL - Israele 5
RS - Serbia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AO - Angola 4
BG - Bulgaria 4
BY - Bielorussia 4
GE - Georgia 4
RO - Romania 4
BB - Barbados 3
BF - Burkina Faso 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
AM - Armenia 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
RE - Reunion 2
Totale 20.391
Città #
Fairfield 1.261
Ashburn 1.200
Woodbridge 902
Singapore 897
Chandler 788
Houston 595
Hong Kong 537
San Jose 536
Seattle 522
Cambridge 476
Wilmington 387
Milan 382
Nyköping 357
Ann Arbor 326
Beijing 306
Jacksonville 280
Council Bluffs 248
New York 232
Los Angeles 168
Bari 165
Lawrence 155
Roxbury 155
Lauterbourg 147
Rome 144
Dallas 134
Munich 118
Ho Chi Minh City 117
Nanjing 113
São Paulo 105
Des Moines 99
Santa Clara 89
Helsinki 81
Princeton 77
Hanoi 70
Buffalo 66
Boardman 65
Brussels 60
Columbus 59
London 59
Brooklyn 58
Inglewood 52
San Diego 52
Dearborn 44
Figino 42
Chicago 39
Jakarta 38
Abidjan 37
Frankfurt am Main 37
Shenyang 36
The Dalles 36
Dong Ket 35
Hebei 34
Redwood City 32
Montreal 31
Turin 31
Rio de Janeiro 30
Tokyo 30
Turku 29
Paris 28
Nanchang 27
Dublin 26
Orem 26
Toronto 26
Baghdad 25
Phoenix 25
Pune 25
Atlanta 24
Brasília 24
Jiaxing 24
Tianjin 24
Boston 22
Falkenstein 22
Belo Horizonte 21
Campinas 21
Moscow 21
San Francisco 20
Changsha 19
Stockholm 19
Mexico City 18
Augusta 17
Chennai 17
Guangzhou 17
Warsaw 17
Curitiba 16
Denver 16
Jeddah 16
Johannesburg 16
Medellín 16
Bogotá 15
Bologna 15
Caracas 15
Tashkent 15
Amsterdam 14
Bitonto 14
Shanghai 14
Dhaka 13
Falls Church 13
Washington 13
Buenos Aires 12
Da Nang 12
Totale 14.001
Nome #
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 270
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 234
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 233
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 223
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 218
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 217
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 211
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 210
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 209
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 201
Isolation and characterization of cancer stem cells in renal cell carcinoma. 199
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 198
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 189
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 188
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 185
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 177
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 175
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 174
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 174
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 173
Allograft nephrectomy: what is the best surgical technique? 173
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 172
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 171
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 168
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 165
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 164
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 163
Penile prosthesis implant: when, what and how 162
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 158
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 158
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 151
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 151
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 149
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 148
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 145
"Deviceless" hand-assisted laparoscopic donor nephrectomy 142
Emerging urinary markers of renal injury in obstructive nephropathy. 141
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 141
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 140
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 140
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 137
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 137
Penile prosthesis: what should we do about complications? 135
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 135
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 132
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 132
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 131
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 131
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 130
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 129
The emerging role of obesity, diet and lipid metabolism in prostate cancer 129
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 129
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 127
Incidental prostatic cancer: repeat TURP or biopsy? 126
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 125
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 125
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 125
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 124
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. 124
Editorial comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation. 123
Emerging biomarkers in renal damage. 123
Obesity in kidney transplantation affects renal function but not graft and patient survival 122
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 121
null 119
Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports 119
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 119
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 118
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 117
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 116
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 113
Hem-O-Lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy 113
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 113
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells 112
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 112
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 111
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 111
Complement Mediated Endothelial Cell (EC) Activation in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 110
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 110
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 110
null 109
Transperitoneal deviceless hand-assisted laparoscopic living donor nephrectomy: an alternative technique for kidney recovery 109
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 108
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 108
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 106
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 106
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 106
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 106
Incidentally discovered yellowish lesions in a renal graft from a deceased donor 106
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 104
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 102
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients 98
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 98
Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. 98
CARCINOMA DELLA PROSTATA 97
Unusual solitary metastasis of the ciliary body in renal cell carcinoma 97
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 97
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 97
Surgery for renal cell carcinoma in two European urologic clinics: to compare or compete? 96
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 96
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 94
Totale 14.073
Categoria #
all - tutte 89.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022943 0 0 18 35 42 103 42 64 71 118 164 286
2022/20231.890 288 228 129 171 187 259 25 239 279 16 45 24
2023/2024663 65 120 38 49 57 230 10 13 5 14 11 51
2024/20253.069 70 73 221 124 88 285 371 271 114 134 455 863
2025/20266.843 1.015 306 449 751 812 359 673 214 631 618 264 751
2026/2027758 146 353 259 0 0 0 0 0 0 0 0 0
Totale 21.011